Search research articles
Contact Us
Filters
Showing results (1-10 of 224) with videos related to
Page
of 23
Sort By:
Cardiovascular Research
|
September 9, 2024
REPRIEVE and CANTOS trials: lessons learned towards eliminating cardiovascular disease in human immunodeficiency virus by combined targeting of LDL and inflammation
Annet Kirabo
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
September 22, 2017
A new paradigm of sodium regulation in inflammation and hypertension
Annet Kirabo
Circulation Research
|
March 2, 2023
Meet the Novel Players in Hypertensive Kidney Disease: Septin4 and SIRT2
Sergey Dikalov, Annet Kirabo
Circulation Research
|
September 14, 2023
α2δ-1 as a New Target for Immunosuppressant-Induced Hypertension
Antentor Hinton, Annet Kirabo
Current Hypertension Reports
|
December 28, 2025
Chemerin as a Mediator of Hypertension and Cardiometabolic Diseases (A Comprehensive Review)
Ronald McMillan, Annet Kirabo
Frontiers in Cardiovascular Medicine
|
June 21, 2023
Hypertensive heart disease: risk factors, complications and mechanisms
Sepiso K Masenga, Annet Kirabo
Cardiovascular Research
|
April 13, 2022
Hypersensitive or hypertensive? IgE-FcɛR1 signalling in mast cells adds a new piece to the immunity and hypertension puzzle
Lale A Ertuglu, Annet Kirabo
Nature Reviews. Cardiology
|
May 28, 2025
Reply to 'Neuroendocrine regulatory effects of sex hormones on salt sensitivity of blood pressure'
Sepiso K Masenga, Annet Kirabo
Kidney360
|
October 17, 2022
Dendritic Cell Epithelial Sodium Channel in Inflammation, Salt-Sensitive Hypertension, and Kidney Damage
Lale A Ertuglu, Annet Kirabo
Frontiers in Physiology
|
June 1, 2023
Editorial: Gut microbiome and metabolic physiology
Jeanne A Ishimwe, Annet Kirabo
Page
of 23
Search research articles
Search
Showing results (1-10 of 224) with videos related to
Sort By:
Page
of 23
Cardiovascular Research
|
September 9, 2024
REPRIEVE and CANTOS trials: lessons learned towards eliminating cardiovascular disease in human immunodeficiency virus by combined targeting of LDL and inflammation
Annet Kirabo
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
September 22, 2017
A new paradigm of sodium regulation in inflammation and hypertension
Annet Kirabo
Circulation Research
|
March 2, 2023
Meet the Novel Players in Hypertensive Kidney Disease: Septin4 and SIRT2
Sergey Dikalov, Annet Kirabo
Circulation Research
|
September 14, 2023
α2δ-1 as a New Target for Immunosuppressant-Induced Hypertension
Antentor Hinton, Annet Kirabo
Current Hypertension Reports
|
December 28, 2025
Chemerin as a Mediator of Hypertension and Cardiometabolic Diseases (A Comprehensive Review)
Ronald McMillan, Annet Kirabo
Frontiers in Cardiovascular Medicine
|
June 21, 2023
Hypertensive heart disease: risk factors, complications and mechanisms
Sepiso K Masenga, Annet Kirabo
Cardiovascular Research
|
April 13, 2022
Hypersensitive or hypertensive? IgE-FcɛR1 signalling in mast cells adds a new piece to the immunity and hypertension puzzle
Lale A Ertuglu, Annet Kirabo
Nature Reviews. Cardiology
|
May 28, 2025
Reply to 'Neuroendocrine regulatory effects of sex hormones on salt sensitivity of blood pressure'
Sepiso K Masenga, Annet Kirabo
Kidney360
|
October 17, 2022
Dendritic Cell Epithelial Sodium Channel in Inflammation, Salt-Sensitive Hypertension, and Kidney Damage
Lale A Ertuglu, Annet Kirabo
Frontiers in Physiology
|
June 1, 2023
Editorial: Gut microbiome and metabolic physiology
Jeanne A Ishimwe, Annet Kirabo
Page
of 23